Literature DB >> 2918113

The dysplastic melanocytic nevus: a prevalent lesion that correlates poorly with clinical phenotype.

M Piepkorn1, L J Meyer, D Goldgar, S A Seuchter, L A Cannon-Albright, M H Skolnick, J J Zone.   

Abstract

We estimated the prevalence of persons with histologic dysplasia in at least one of two nevi examined by biopsy to be 53% in Utah's caucasians. This apparently high prevalence indicates that such lesions may represent a normal variant of a melanocytic nevus, perhaps those in the process of active proliferation. Regardless of the apparent ubiquity of these lesions, examination of biopsy specimens led to a grading scheme of histologic dysplasia that may reflect chronologic stages in the neoplastic development of melanocytic nevi. Comparison of these histologic findings with the clinical examination yielded the unexpected result that dysplasia and lesion size are independent of each other. Lesions 3 mm in diameter or smaller were as likely to be dysplastic as those much larger. There was, however, a statistically significant relationship between histologic dysplasia of a nevus examined by biopsy and the person's total number of melanocytic lesions. This finding indicates that the pathology grading scheme may be useful. The high prevalence of dysplastic nevi dilutes the clinical significance of a dysplastic nevus as an isolated finding and thereby lessens the importance of pathologic findings in the diagnosis of dysplastic nervus syndrome.

Entities:  

Mesh:

Year:  1989        PMID: 2918113     DOI: 10.1016/s0190-9622(89)70050-5

Source DB:  PubMed          Journal:  J Am Acad Dermatol        ISSN: 0190-9622            Impact factor:   11.527


  10 in total

1.  Histopathological characteristics of small diameter melanocytic naevi.

Authors:  M Braun-Falco; R Hein; J Ring; N S McNutt
Journal:  J Clin Pathol       Date:  2003-06       Impact factor: 3.411

Review 2.  An update on molecular alterations in melanocytic tumors with emphasis on Spitzoid lesions.

Authors:  Emmanouil Dimonitsas; Aliki Liakea; Stratigoula Sakellariou; Irene Thymara; Andreas Giannopoulos; Alexandros Stratigos; Efthymia Soura; Angelica Saetta; Penelope Korkolopoulou
Journal:  Ann Transl Med       Date:  2018-06

3.  The dysplastic nevus: from historical perspective to management in the modern era: part I. Historical, histologic, and clinical aspects.

Authors:  Keith Duffy; Douglas Grossman
Journal:  J Am Acad Dermatol       Date:  2012-07       Impact factor: 11.527

4.  Further evidence for a locus for cutaneous malignant melanoma-dysplastic nevus (CMM/DN) on chromosome 1p, and evidence for genetic heterogeneity.

Authors:  A M Goldstein; N C Dracopoli; E C Ho; M C Fraser; K S Kearns; S J Bale; O W McBride; W H Clark; M A Tucker
Journal:  Am J Hum Genet       Date:  1993-03       Impact factor: 11.025

Review 5.  Hereditary melanoma and the search for the melanoma gene.

Authors:  R F Kefford
Journal:  World J Surg       Date:  1992 Mar-Apr       Impact factor: 3.352

Review 6.  The molecular pathology of melanoma: an integrated taxonomy of melanocytic neoplasia.

Authors:  Boris C Bastian
Journal:  Annu Rev Pathol       Date:  2014       Impact factor: 23.472

7.  Evidence against the reported linkage of the cutaneous melanoma-dysplastic nevus syndrome locus to chromosome Ip36.

Authors:  L A Cannon-Albright; D E Goldgar; E C Wright; A Turco; M Jost; L J Meyer; M Piepkorn; J J Zone; M H Skolnick
Journal:  Am J Hum Genet       Date:  1990-05       Impact factor: 11.025

Review 8.  Melanoma risk factors and atypical moles.

Authors:  M L Williams; R W Sagebiel
Journal:  West J Med       Date:  1994-04

9.  Diagnostic assessment of two novel proliferation-specific antigens in benign and malignant melanocytic lesions.

Authors:  P Rudolph; T Lappe; C Schubert; D Schmidt; R M Parwaresch; E Christophers
Journal:  Am J Pathol       Date:  1995-12       Impact factor: 4.307

10.  On the clinical significance of cutaneous melanoma's precursors.

Authors:  Giuseppe Noto
Journal:  Indian Dermatol Online J       Date:  2012-05
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.